https://doi.org/10.4081/cc.2024.15761
ID-Migraine test for pediatric population: preliminary results from the Italian validation
Submitted: 20 March 2024
Accepted: 14 April 2024
Published: 7 May 2024
Accepted: 14 April 2024
Abstract Views: 1877
PDF: 348
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Background: Migraine is a frequent neurological condition with a high impact on quality life. The diagnosis is clinical in accordance with the International Classification of Headache Disorders version 3 criteria. Early diagnosis is important to initiate timely treatment. A screening tool for adulthood is already available (ID-Migraine), while there is currently no questionnaire that allows for diagnosis in children and adolescents. The aim of the present study is to demonstrate the validity of ID-Migraine to diagnose migraine in pediatric population.
Methods: A total of 94 pediatric patients were enrolled and administered ID-Migraine. The mean age was 11.6 years. The study group included patients with a diagnosis of migraine (63%) and primary stabbing headache (37%).
Results and conclusions: Specificity and positive predictive values were >80% (92% and 93% respectively); sensitivity and negative predictive values tended towards reliability (71% and 66% respectively), making the ID-Migraine a reliable tool in diagnosing migraine in the pediatric population.
Abu‐Arafeh I, Razak S, Sivaraman B, Graham C. Prevalence of headache and migraine in children and adolescents: a systematic review of population‐based studies. Dev Med Child Neurol 2010;52:1088-97.
DOI: https://doi.org/10.1111/j.1469-8749.2010.03793.x
Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1211-59.
DOI: https://doi.org/10.1016/S0140-6736(17)32154-2
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38:1-211.
DOI: https://doi.org/10.1177/0333102417738202
Torriero R, Capuano A, Mariani R, Frusciante R, Tarantino S, Papetti L, et al. Diagnosis of primary headache in children younger than 6 years: a clinical challenge. Cephalalgia 2017;37:947-54.
DOI: https://doi.org/10.1177/0333102416660533
Özge A, Faedda N, Abu-Arafeh I, Gelfand AA, Goadsby PJ, Cuvellier JC, et al. Experts’ opinion about the primary headache diagnostic criteria of the ICHD-3rd edition beta in children and adolescents. J Headache Pain 2017;18:109.
DOI: https://doi.org/10.1186/s10194-017-0818-y
Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, et al. A self-administered screener for migraine in primary care: the ID MigraineTM validation study. Neurology 2003;61:375-82.
DOI: https://doi.org/10.1212/01.WNL.0000078940.53438.83
Brighina F, Salemi G, Fierro B, Gasparro A, Balletta A, Aloisio A, et al. A validation study of an Italian version of the ID Migraine. Headache 2007;47:905-8.
DOI: https://doi.org/10.1111/j.1526-4610.2006.00628.x
Zarifoğlu M, Karli N, Taşkapilioğlu Ö. Can ID Migraine TM be used as a screening test for adolescent migraine? Cephalalgia 2008;28:65-71.
DOI: https://doi.org/10.1111/j.1468-2982.2007.01470.x
Jin Z, Shi L, Wang YJ, Yang LG, Shi YH, Shen LW, et al. Prevalence of headache among children and adolescents in Shanghai, China. J Clin Neurosci 2013;20:117-21.
DOI: https://doi.org/10.1016/j.jocn.2012.02.020
Monte G, Papetti L, Ursitti F, Sforza G, Tarantino S, Checchi Proietti M, et al. Childhood primary stabbing headache: a double center study. Cephalalgia 2024;44:03331024231225974.
DOI: https://doi.org/10.1177/03331024231225974
How to Cite
1.
Frattale I, Papetti L, Ursitti F, Sforza G, Monte G, Mazzone L, et al. ID-Migraine test for pediatric population: preliminary results from the Italian validation. Confinia Cephalal [Internet]. 2024 May 7 [cited 2024 Dec. 21];34(1). Available from: https://www.confiniacephalalgica.com/site/article/view/15761
Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Sarah Cargnin, Salvatore Terrazzino, Ennio Pucci, Michele Viana, Drug resistance to triptans: a problem for thousands of people in Italy , Confinia Cephalalgica: Vol. 26 No. 1 (2016)
- Michele Viana, Giuseppe Nappi, Cyclic migraine. From pathophysiological understanding to therapeutic opportunities in patients with migraine attacks showing predictable periodicity , Confinia Cephalalgica: Vol. 26 No. 1 (2016)
- Simona Guerzoni, Flavia Lo Castro, Carlo Baraldi, Daria Brovia, Fabio Tascedda, Veronica Rivi, Luca Pani, Anti-CGRP monoclonal antibodies improve cognitive function in patients affected by chronic migraine complicated with medication overuse-headache , Confinia Cephalalgica: Vol. 34 No. 1 (2024)
- Giulia Paparella, Chiara Abbatantuono, Livio Clemente, Stefania Scannicchio, Marina de Tommaso, Cognitive reserve and well-being in migraine patients: a multidimensional approach to migraine assessment in an Italian tertiary headache center , Confinia Cephalalgica: Vol. 34 No. 1 (2024)
- Roberto Tedeschi, Manual trigger point treatment in migraine management: a scope review , Confinia Cephalalgica: Vol. 34 No. 2 (2024)
- Mariano Martini, Francesco Brigo, Davide Orsini, The history of Italian neuropsychiatry and the role of Onofrio Fragnito (1871-1959) , Confinia Cephalalgica: Vol. 33 No. 2 (2023)
- Marina Romozzi, Andrea Burgalassi, Catello Vollono, Maria Albanese, Giulia Vigani, Francesco De Cesaris, Alberto Chiarugi, Paolo Calabresi, Luigi Francesco Iannone, Prospective evaluation of aura during anti-calcitonin gene-related peptide monoclonal antibody therapy after 52 weeks of treatment , Confinia Cephalalgica: Vol. 34 No. 1 (2024)
- Damiana Scuteri, Martina Pagliaro, Andrea Monteleone, Assunta Tarsitano, Rosario Iannacchero, Marilù Vulnera, Giorgio Sandrini, Paolo Tonin, Giacinto Bagetta, Maria Tiziana Corasaniti, Proposal of combination therapies to treat refractory chronic migraine , Confinia Cephalalgica: Vol. 33 No. 3 (2023)
- Francesco Casillo, Chiara Abagnale, Gabriele Sebastianelli, Antonio Di Renzo, Vincenzo Parisi, Ettore Cioffi, Mariano Serrao, Cherubino Di Lorenzo, Cortical excitability in patients with migraine with aura and depressive symptoms: a visual evoked potentials study , Confinia Cephalalgica: Vol. 34 No. 1 (2024)
- Michele Corrado, Elena Mazzotta, Gloria Vaghi, Francescantonio Cammarota, Federico Bighiani, Alessandro Antoniazzi, Daniele Martinelli, Maria Magdalena Pocora, Luca Martinis, Valentina Grillo, Sara Bottiroli, Armando Perrotta, Giuseppe Cosentino, Grazia Sances, Cristina Tassorelli, Roberto De Icco, Normative values of the nociceptive blink reflex habituation , Confinia Cephalalgica: Vol. 34 No. 1 (2024)
You may also start an advanced similarity search for this article.
